Apexigen Inc.

NASDAQ: APGN · Real-Time Price · USD
0.39
0.04 (9.86%)
At close: Aug 22, 2023, 9:59 PM

Apexigen Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost of Revenue
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Operating Income
-6.16M -6.22M -6.65M -8.8M -1.78B -9.09M -8.1M -7.31M -163.52M -6.5M
Interest Income
n/a n/a n/a n/a n/a 52K n/a n/a n/a 15K
Pretax Income
-6.05M -6.05M -6.43M -8.49M -1.67B -9.04M -8.09M -7.3M -281.58M -6.49M
Net Income
-6.05M -5.89M -6.54M -8.19M -1.56B -9.04M -8.09M -7.3M -281.58M -6.49M
Selling & General & Admin
4.41M 3.28M 2.41M 3.12M 1.76B 1.99M 1.56M 1.81M 143.07M 1.54M
Research & Development
1.75M 2.94M 4.24M 5.68M n/a 7.11M 6.54M 5.5M n/a 4.96M
Other Expenses
111K 163K 219K 307K 17.16M n/a n/a 7K n/a n/a
Operating Expenses
6.16M 6.22M 6.65M 8.8M 1.78B 9.09M 8.1M 7.31M 163.52M 6.5M
Interest Expense
n/a n/a n/a n/a 7.11M n/a n/a n/a n/a n/a
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Cost & Expenses
6.16M 6.22M 6.65M 8.8M 1.78B 9.09M 8.1M 7.31M 163.52M 6.5M
Income Tax Expense
n/a -163K 106.83K -307K -114.2M n/a n/a n/a n/a n/a
Shares Outstanding (Basic)
24.73M 24.16M 19.79K 20.48M 6.94M 31.4M 31.07M 31.07M 6.94M 6.94M
Shares Outstanding (Diluted)
24.73M 24.16M 19.79K 20.48M 6.94M 31.4M 31.07M 31.07M 31.07M 31.07M
EPS (Basic)
-0.24 -0.24 -330.41 -0.4 -224.74 -0.29 -0.26 -0.23 -40.6 -0.94
EPS (Diluted)
-0.24 -0.24 -330.41 -0.4 -224.74 -0.29 -0.26 -0.23 -9.06 -0.21
EBITDA
-6.16M -6.2M -6.62M -8.8M -1.78B -9.07M -8.07M -7.31M -163.52M -6.48M
EBIT
n/a n/a -13.59M -8.85M -1.67B n/a n/a n/a n/a n/a
Depreciation & Amortization
122.08K 17K 26K 52K 86.06K 28K 26K 54K 55.81K 26K